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({We have entered the cell, the mansion of our birth,






This is the first issue of a new quarterly publication from The
Rockefeller University. As its name implies, each issue will profile
an area of research at The Rockefeller, not only to report what's
new and what looks promising, but also to help convey something of
the process of science.
Vincent Al/frey and his colleagues, whose work is described in
this issue, comprise one ofmore than 60 laboratory groups at work
on the University's 15-acre campus in New York City. They are
heirs to a 79-year tradition defined by the University's motto, pro
bono humani generis-for the good of humankind.
When the University began, as The Rockefeller Institute for
Medical Research, it was the only such institution in the country.
It remains today one of the world's leading centers /or biomedical
science, having added along the way the country's first hospital
dedicated solely to clinical research, distinguished faculties in the
physical, mathematical, and behaviorial sciences, a';d a graduate
education program that, in its brief 25-year span, has produced
two Nobel Prize winners.
All scientific enterprise begins as a quest for deeper understand-
in~ of the. natural wor/d. Implicit is the hope that the knowledge
gamed WIll mdeed contribute to human good. Or, as Dr. Al/frey
puts it: "In basic research you always have the conviction that
what you do is going to have a practical outcome. The question is,
Where?"
o




"With regard to the process by which a cell becomes trans-
formed to a tumor, I have always been convinced that studies
of gene control are at the heart of it. That is, to really under-
stand how cancer happens you have to understand"gene con-
trol. It may be, of course, that tumors will eventually be han-
dled by some immunological or other process and thar our
more basic approaches will not turn out to be that urgent
clinically. But I still think it's important to know why a tumor
develops, what the inirial events are-whether ir's simply
DNA damage or an upset of the control mechanism of the
cell. And since we do find that rhe concrol mechanisms are
alrered in tumor cells, rhar's rhe aspecr of cancer rhat firs into
rhe interests of my laboratory."
Professor Vincent G. Allfrey, quored above, is a cell biolo-
gisr who has spent more rhan 30 of his 58 years at The Rock-
efeller Universiry, mosr of them peering and probing inro the
nucleus of the living cell. Specifically, his research cemers on
rhe role of nuclear proreins in the control of gene srrucrure
and funcrion. His work began as an anempr ro understand the
mechanisms of gene control. Now, many years later, some
Electron-micrograph shows
chromatin (magnified 100, 000
times) in inactive state. DNA
strands are tightly wrapped
around histone"cores"
(nuc!eosomes), each of which
contains eight histone molecules.
(Drawing on page 4 shows
possible ways in which
nuc!eosomes are altered when
genes are activated.)
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lines of this research are beginning to relate to cancer pro-
cesses: studies of changes in the nuclear proteins of cells
undergoing transformation to the malignant state in response
to chemical carcinogens, and new approaches to cancer che-
motherapy based on the inhibition of protein synthesis.
WHAT SWITCHES GENES ON?
As Dr. Allfrey explains: "The activity of every living cell is
determined by its genetic material, deoxyribonucleic acid-
DNA. In higher organisms, the DNA is concentrated inside
Dr. Allfrey
the cell nucleus, in association with a number of proteins, on
threadlike structures called chromosomes. Every cell contains
within its chromosomes all the information necessary for the
manufacture of every protein in the entire organism. Proteins
are the principal functional constituents and structural ele-
ments of living matter.
"But no cell uses all that information. It uses only a small
fraction, perhaps ten percent. Even so, it may be making
10,000 different proteins. However, many of the 10,000 pro-
teins expressed in a liver cell are specialized, different from
the proteins in a brain cell, while many are common proteins,
needed for basic housekeeping functions. If you look at a
pancreas cell and a red blood cell, you find that one is making
digestive enzymes and the other hemoglobin. Each cell has
the same information in its nucleus. Each could be doing what
the other does, but it doesn't. What determines what informa-
tion gets used? What switches on certain genes in the DNA?
What is the difference in the chromosomes of those two cells?
That's what we want to find out."
For the information in the genes to be activated, or, in the
language of the' geneticist, expressed, the genes' chemical
code must be encoded in another chemical, a form of ribo-
nucleic acid called mRNA, the m standing for messenger.
Each mRNA carries a coded message to the ribosomes, the
organelles in the cell where the message is "read" and the
synthesis of specific proteins,takes place. The process of mes-
sage-copying from the DNA template is catalyzed by other
kinds of proteins called RNA polymerases, enzymes which
assemble the RNA chain from smaller subunits. If the DNA
is not accessible to the polymerases, the DNA is essentially
nonfunctional.
If stretched out to its full length, the DNA in a single
human cell would form a thin fiber about a yard long. But the
cell has to stOre all this material in a very tiny space within the
nucleus-only a few 10,000ths of an inch in diameter. To
achieve this compaction, the DNA coils around clusters of
small proteins called histones, which are predominandy
found in 'core' particles that contain eight histone molecules.
The DNA makes two wraps around a cluster, moves on to the
next cluster, and so forth.
"There is a lot of pretty solid evidence," Dr. Allfrey notes,
"from work done in our lab and in other labs over the last 20
or 25 years, that histones and other DNA-binding proteins
control structure and influence the activity of the genes. Ulti-
mately, we hope to determine which proteins control which
genes. We apply our experiments to a variety of systems: nor-
mal cells during embryonic differentiation, cells responding
to hormones, and cells responding to carcinogens."
THE APPRENTICE YEARS
Like the University itself, Dr. Allfrey's lab, on the eighth
floor of the Tower Building, attracts scientists from all over
the world; but Dr. Allfrey is a native New Yorker, born not
very far from the University's campus on the east side of
Manhattan. His interest in chemistry was nurtured at Stuyve-
sant High School, which for generations has attracted New
York youngsters enthusiastic about science. He was still in his
teens when he cook his first job at The Rockefeller, as a lab
helper, to help put himself through night classes at City Col-
lege. After college and military service in World War II, he
spent another year at the University as a technician before
going to graduate school.
The years of his apprenticeship coincided with some of the
most significant events in modern cell research, a good
number of which happened at The Rockefeller. Albert
Claude, George Palade, Keith Porter, and a succession of
gifted colleagues developed techniques for using the electron
microscope to study the deep structure of cells, beyond the
reach of the light microscope. Almost concurrently, they
introduced the cell fractionation technique for simulta-
neously breaking up billions of cells and isolating for analysis
the tiny organelles revealed by this powerful new cool. The
first electron micrograph of this new world within the cell was
made by Claude, Porter, and Edward Fullam in 1944. Two
years later, Claude published two papers summarizing a
decade of work on fractionation of mammalian cells by use of
the high-speed centrifuge.
Looking back on those revolutionary discoveries and
related advances by scientists at The Rockefeller University
and elsewhere that produced methods for analyzing cellular
components chemically, Dr. Allfrey observes: "What they did
was bring it all cogether-a combination of microscopy, cell
fractionation, and biochemical techniques-so you could
make a concerted attack on such very important problems as
how proteins get made and secreted."
The same year the first electron micrograph was taken,
three ocher scientists at The Rockefeller, Oswald T. Avery,
Colin MacLeod, and Maclyn McCarty, identified DNA as the
material of the genes-the blueprint of life-an event that
has since been described as the greatest discovery.of biologi-
cal science in this century.
The DNA story provides a wonderful example of the
unpredictable ways of science. Avery and his co-workers
were not, strictly speaking, geneticists or cell biologists. They
were bacteriologists at the Rockefeller Hospital, trying to
come up with a treatment or preventive vaccine for pneumo- ,
nia. They did come up with a serum treatment, the best that
was available until the advent of antibiotics. But they also
found that DNA from one strain of the pneumonia bacterium
could enter and transform another strain conferring upon it
and its progeny the capacity to make a new type of cell sur-
face. In other words, the DNA was carrying genetic informa-
tion from one bacterial strain to another. (Among his duties,
the young lab helper, Vincent Allfrey, purified batches of
pneumococcal DNA for Avery's studies.)
During this period, also, Alfred Mirsky first isolated chro-
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In the technique called gel
electrophoresis, radioactively
charged molecules (proteins,
RNA, DNA) migrate through a
viscous medium (gel) to different
positions, forming distinct bands.
The location of the bands
identifies the molecules and the
intensity of the radioactivity in
each band measures the number of
labeled molecules. Dr. Giorgio
Vidali works with an
electrophoretogram scanner
designed by two Rockefeller
physicists and a graduate student
in chemical biology. Their new
instrument greatly speeds the
process -15 minutes as opposed
to days or weeks -and improves
its accuracy.
matin-the chromosome's mixture of DNA, histones, and
other proteins-from mammalian cells, and he provided the
first evidence that all the cells (except ova and spermatozoa)
in the body of an individual of a species contain the same
amount of DNA, Years later, the Mirsky laboratory, of which
by then Vincent Allfrey was a member, announced the results
of experiments confirming that RNA was the agent that
copies and transports the message of DNA within the cells.
PROTEINS AND GENES:
A KEY DISCOVERY
Dr. Allfrey was invited to join the Mirsky lab in 1949 after he
had completed his Ph.D. at Columbia University. "From the
start with Dr. Mirsky," he recalls, "my interest was in chro-
mosomes and proteins. There were a number of laboratories,
here and elsewhere, doing work on protein synthesis in the
ribosomes, but ours was the first to get into nucleoprotein
synthesis. I always smile when I think back to that time and
about the details of research that don't get into the scientific
papers. Some of the experiments we were doing required
large organs from which we could extract a lot of nuclei. We
got some of them from a slaughterhouse in New Jersey. I
remember once I was coming back carrying a box with a horse
liver in it, wrapped in waxed paper-we didn't have plastic in
those days. It started to leak allover the Third Avenue ele-
vated subway. People would come into the car, sit down next
to me, notice the trail of blood, and move away pretty fast.
"From the work on protein synthesis, I got interested in
histones. The first suggestion that histones might have a role
in gene regulation came in the early 1950s. By that time, a
number of laboratories were working on the problem. In
time, people began to deduce that histones depress RNA syn-
thesis. In 1964, my group made a discovery that really began
to put the whole story together. What we discovered was a
Possible alterations in nucleosome structure at times of gene activation:
DNA helix tightly coiled around histone octet (A) is virtually inactive
as a template for RNA synthesis. A relaxation of the histone clamps
releases constraints on the DNA and makes it more accessible to
RNA-synthesizing enzymes. This is achieved by acetylation of the
DNA -binding eWmains of each histone molecule. The result may be an




post-synthetic modification in the histones and we knew it
had to have something to do with transcription." (By "post-
synthetic" Dr. Allfrey means a change in the protein after it's
been made and shipped into the nucleus.)
Histones and other nuclear proteins interact with DNA
because the proteins' basic amino acids, like lysine, carry a
positive charge which binds electrostatically with negatively
charged phosphate groups on the DNA molecule. The pro-
tein and the DNA molecules lock together. Dr. Allfrey and
his colleagues discovered enzymatic mechanisms that neutral-
ize the positive charge on the histones and permit release of
the constraints on the DNA helix.
"The reaction we discovered was acetylation," Dr. Allfrey
says. "That is, the enzyme introduces an acetate group onto a
lysine component of a histone and wipes out its positive
charge. As the enzyme moves, zipper-fashion, along the
DNA-binding region of the histone molecule, many lysine
residues are modified and the histone may fall away from the
DNA, leaving the DNA accessible, free to perform whatever
function it needs to. An increase in acetylation of the histones
is usually followed, within half an hour, by an increase in
RNA synthesis.
"In retrospect, it sounds simple but it rook several years of
work before we had it figured out. In 1968, my colleagues
Giorgio Vidali and Edward Gershey-Ed was still in graduate
school-and I discovered that the modification involved the
formation of N-acetyl lysine. With that, the whole chemical
picture became clearer. Until then we knew only that acetyla-
tion correlated with gene activity-it was an early event in
gene activation-but we didn't know why. We could only
guess. Finally we had proof that a modification of the lysine
residue neutralizes the charge, chemical proof that you relax
the constraints on the DNA by acetylating the associated his-
tones. We've been following the ramifications of that ever
since in one form or another."
Acetylation is only one kind of chemical activity affecting
the nuclear proteins. There are others, more complex, called




"Given the evidence that these processes affect both the
structure and function of the chromatin in normal cells," Dr,
Allfrey continues, "it was natural ro ask whether the proteins
of the nucleus are involved in cell malignancy. We staned by
studying the nuclei of epithelial cells in the colons of rats
injected with the chemical carcinogen, 1,2-dimethyl-hydra-
zine (DMH). An early and progressive increase in the synthe-
sis of TNP-l, a specific nuclear protein class, was detected
long before there were any morphological indications of
malignancy, that is, changes in the cell structure. Similar pro-
teins were found in studies of the nuclei of human colon
cancer cells. So, now we are studying these proteins and their
role in chromosome structure and function to seek to pro-
duce antibodies that might make possible early detection of
colonic .cancer. This is important for treatment to be
effective.
"Another aspect of our cancer work was stimulated by a
1974 repon on the use of urea to inhibit skin cancer and ro
extend the survival of patients with liver cancer. We specu-
lated that sodium cyanate often present in urea might be the
tumor-inhibiting component. Dr.. Ldia Boffa and I tested
cyanate with our colonic-tumor rats and found that it did
selectively inhibit protein synthesis in the tumor cells without
any appreciable effects on the animals' normal tissues. We
discovered that the cyanate must first be metabolized in the
animal's liver to produce an active ami-tumor agent. But we
want to know how the cyanate works selectively against
tumor cells. Here we get back to acetylation.
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Dr. Alfjrey (left) with Dr. Hans-Peter Hoffmann, at the
electron microscope.
"Histone acetylation occurs very early in the course of gene
activation in cells that are responding to hormones and other
developmental stimuli. Conversely, the removal of acetate
from histones by enzyme action correlates with gene inactiva-
tion in a number of cell types. Recently we showed that a
simple organic acid salt, sodium butyrate, inhibits the action
of enzymes that remove the acetate group from histones. This
disrupts the normal dynamic balance berween acetate uptake
and release, and cells exposed to butyrate gradually accumu-
late hyper-acetylated histones. These cells often show altered
gene activity such as abnormal hormone or enzyme produc-
tion, and tumor cells exposed to butyrate lose many of their
malignant growth characteristics.
"The butyrate-induced change in histone structure is essen-
tially freeing up the DNA-making it more accessible. You
can see the chromosome changes in the electron microscope.
As a result, you suddenly get an activation of many of the
genes that were previously being expressed at low level or not
at all.
"We've used this phenomenon as a tool to analyze the cyan-
ate effect. We've found that tumor cells placed in butyrate for
a while are not sensitive to cyanate any more. However, the
process is reversible. So, what we have now is an experimen-
tal system to observe these changes. We can actually look at
changes that are significant in the expression of malignancy by
varying the butyrate concentrations-putting it in and taking
it Out of the medium.
"In other words, what we're trying to do is to look at all
these nucleoproteins with the new techniques in order to
determine which proteins appeared, which disappeared, what
changes occurred~ how and when they responded to various
stimuli, and then tie the whole thing together.
"We certainly didn't start out with any plan to put histone
acetylation and cyanate sensitivity together and relate it to
cancer, but that's how it seems to be working out. I guess
thac's how science is." 0
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